The primary objective of this protocol is to provide access to SU011248 treatment forpatients with metastatic RCC who are ineligible for participation in ongoing SU011248clinical studies and have the potential to derive clinical benefit from treatment withSU011248 based on the judgment of the investigator.
Given that an Expanded Access study does not meet the definition of a controlled clinical
investigation, and as such, is not considered an applicable drug clinical trial per NIH,
Basic Results for such studies are not required to be reported. Protocol A6181037 has
been identified as an Expanded Access trial, and has been registered to
ClinicalTrials.gov, however Basic Results will not be posted.
Drug: Sutent
Sutent, 25, 37.5. or 50 mg daily
Inclusion Criteria:
- renal cell carcinoma that is not amendable to standard therapy with curative intent
Exclusion Criteria:
- current treatment in another therapeutic clinical trial
Pfizer Investigational Site
Scottsdale, Arizona, United States
Pfizer Investigational Site
San Francisco, California, United States
Pfizer Investigational Site
San Francisco, California, United States
Pfizer Investigational Site
Aurora, Colorado, United States
Pfizer Investigational Site
Norwalk, Connecticut, United States
Pfizer Investigational Site
Miami, Florida, United States
Pfizer Investigational Site
Ocala, Florida, United States
Pfizer Investigational Site
Tampa, Florida, United States
Pfizer Investigational Site
Atlanta, Georgia, United States
Pfizer Investigational Site
Maywood, Illinois, United States
Pfizer Investigational Site
Indianapolis, Indiana, United States
Pfizer Investigational Site
Council Bluffs, Iowa, United States
Pfizer Investigational Site
Covington, Louisiana, United States
Pfizer Investigational Site
Gretna, Louisiana, United States
Pfizer Investigational Site
Marrero, Louisiana, United States
Pfizer Investigational Site
Metairie, Louisiana, United States
Pfizer Investigational Site
Metairie, Louisiana, United States
Pfizer Investigational Site
New Orleans, Louisiana, United States
Pfizer Investigational Site
Baltimore, Maryland, United States
Pfizer Investigational Site
Boston, Massachusetts, United States
Pfizer Investigational Site
Boston, Massachusetts, United States
Pfizer Investigational Site
Boston, Massachusetts, United States
Pfizer Investigational Site
Detroit, Michigan, United States
Pfizer Investigational Site
Minneapolis, Minnesota, United States
Pfizer Investigational Site
Southaven, Mississippi, United States
Pfizer Investigational Site
Tupelo, Mississippi, United States
Pfizer Investigational Site
Columbia, Missouri, United States
Pfizer Investigational Site
Columbia, Missouri, United States
Pfizer Investigational Site
Omaha, Nebraska, United States
Pfizer Investigational Site
Bronx, New York, United States
Pfizer Investigational Site
New York, New York, United States
Pfizer Investigational Site
New York, New York, United States
Pfizer Investigational Site
Durham, North Carolina, United States
Pfizer Investigational Site
Cleveland, Ohio, United States
Pfizer Investigational Site
Norman, Oklahoma, United States
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States
Pfizer Investigational Site
Oklahoma City, Oklahoma, United States
Pfizer Investigational Site
Tulsa, Oklahoma, United States
Pfizer Investigational Site
Tulsa, Oklahoma, United States
Pfizer Investigational Site
Portland, Oregon, United States
Pfizer Investigational Site
Portland, Oregon, United States
Pfizer Investigational Site
Hershey, Pennsylvania, United States
Pfizer Investigational Site
Memphis, Tennessee, United States
Pfizer Investigational Site
Memphis, Tennessee, United States
Pfizer Investigational Site
Dallas, Texas, United States
Pfizer Investigational Site
Salt Lake City, Utah, United States
Pfizer Investigational Site
Seattle, Washington, United States
Pfizer Investigational Site
Seattle, Washington, United States
Pfizer Investigational Site
Seattle, Washington, United States
Pfizer Investigational Site
Seattle, Washington, United States
Pfizer Investigational Site
Madison, Wisconsin, United States
Pfizer Investigational Site
Buenos Aires, Argentina
Pfizer Investigational Site
Buenos Aires, Argentina
Pfizer Investigational Site
Buenos Aires, Argentina
Pfizer Investigational Site
Randwick, New South Wales, Australia
Pfizer Investigational Site
St Leonards, New South Wales, Australia
Pfizer Investigational Site
Westmead, New South Wales, Australia
Pfizer Investigational Site
South Brisbane, Queensland, Australia
Pfizer Investigational Site
Elizabeth Vale, South Australia, Australia
Pfizer Investigational Site
Woodville South, South Australia, Australia
Pfizer Investigational Site
East Melbourne, Victoria, Australia
Pfizer Investigational Site
Heidelburg, Victoria, Australia
Pfizer Investigational Site
Perth, Western Australia, Australia
Pfizer Investigational Site
Innsbruck, Austria
Pfizer Investigational Site
Wien, Austria
Pfizer Investigational Site
Bruxelles, Belgium
Pfizer Investigational Site
Bruxelles, Belgium
Pfizer Investigational Site
Gent, Belgium
Pfizer Investigational Site
Leuven, Belgium
Pfizer Investigational Site
Liege, Belgium
Pfizer Investigational Site
Wilrijk, Belgium
Pfizer Investigational Site
Sarajevo, Bosnia and Herzegovina
Pfizer Investigational Site
Salvador, BA, Brazil
Pfizer Investigational Site
Belo Horizonte, MG, Brazil
Pfizer Investigational Site
Porto Alegre, Rio Grande do Sul, Brazil
Pfizer Investigational Site
Rio de Janeiro, RJ, Brazil
Pfizer Investigational Site
Rio de Janeiro, RJ, Brazil
Pfizer Investigational Site
Porto Alegre, RS, Brazil
Pfizer Investigational Site
Jau, SP, Brazil
Pfizer Investigational Site
Jaú, SP, Brazil
Pfizer Investigational Site
Jaú, SP, Brazil
Pfizer Investigational Site
São Paulo, SP, Brazil
Pfizer Investigational Site
São Paulo, SP, Brazil
Pfizer Investigational Site
São Paulo, SP, Brazil
Pfizer Investigational Site
Sofia, Bulgaria
Pfizer Investigational Site
Sofia, Bulgaria
Pfizer Investigational Site
Calgary, Alberta, Canada
Pfizer Investigational Site
Edmonton, Alberta, Canada
Pfizer Investigational Site
Kelowna, British Columbia, Canada
Pfizer Investigational Site
Vancouver, British Columbia, Canada
Pfizer Investigational Site
Victoria, British Columbia, Canada
Pfizer Investigational Site
Winnipeg, Manitoba, Canada
Pfizer Investigational Site
Winnnipeg, Manitoba, Canada
Pfizer Investigational Site
St. John's, Newfoundland and Labrador, Canada
Pfizer Investigational Site
Halifax, Nova Scotia, Canada
Pfizer Investigational Site
Halifax, Nova Scotia, Canada
Pfizer Investigational Site
London, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Toronto, Ontario, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Montreal, Quebec, Canada
Pfizer Investigational Site
Quebec, Canada
Pfizer Investigational Site
Santiago, RM, Chile
Pfizer Investigational Site
Bogotá, Cundinamarca, Colombia
Pfizer Investigational Site
Cali, Colombia
Pfizer Investigational Site
Rijeka, Croatia
Pfizer Investigational Site
Split, Croatia
Pfizer Investigational Site
Brno, Czech Republic
Pfizer Investigational Site
Hradec Kralove, Czech Republic
Pfizer Investigational Site
Praha 5, Czech Republic
Pfizer Investigational Site
Praha 8, Czech Republic
Pfizer Investigational Site
Guayaquil, Guayas, Ecuador
Pfizer Investigational Site
Quito, Pichincha, Ecuador
Pfizer Investigational Site
Cairo, Egypt
Pfizer Investigational Site
Giza, Egypt
Pfizer Investigational Site
Turku, Finland
Pfizer Investigational Site
Lyon, Cedex 08, France
Pfizer Investigational Site
Saint Herblain, Cedex, France
Pfizer Investigational Site
Strasbourg, Cedex, France
Pfizer Investigational Site
Bordeaux, France
Pfizer Investigational Site
Clermont Ferand, France
Pfizer Investigational Site
Marseille Cedex 9, France
Pfizer Investigational Site
Marseille, France
Pfizer Investigational Site
Montpellier, France
Pfizer Investigational Site
Paris Cedex 13, France
Pfizer Investigational Site
Paris, France
Pfizer Investigational Site
Reims, France
Pfizer Investigational Site
Rennes, France
Pfizer Investigational Site
Tours, France
Pfizer Investigational Site
Vandoeuvre les Nancy, France
Pfizer Investigational Site
Aachen, Germany
Pfizer Investigational Site
Berlin, Germany
Pfizer Investigational Site
Dresden, Germany
Pfizer Investigational Site
Essen, Germany
Pfizer Investigational Site
Frankfurt, Germany
Pfizer Investigational Site
Freiburg, Germany
Pfizer Investigational Site
Hamburg, Germany
Pfizer Investigational Site
Hannover, Germany
Pfizer Investigational Site
Homburg/Saar, Germany
Pfizer Investigational Site
Jena, Germany
Pfizer Investigational Site
Kassel, Germany
Pfizer Investigational Site
Muenchen, Germany
Pfizer Investigational Site
Nuernberg, Germany
Pfizer Investigational Site
Rostock, Germany
Pfizer Investigational Site
Ulm, Germany
Pfizer Investigational Site
Athens, Attiki, Greece
Pfizer Investigational Site
Athens, Greece
Pfizer Investigational Site
Patras, Greece
Pfizer Investigational Site
Thessaloniki, Greece
Pfizer Investigational Site
Hong Hong, Hong Kong
Pfizer Investigational Site
Budapest, Hungary
Pfizer Investigational Site
New Delhi, Delhi, India
Pfizer Investigational Site
Pune, Maharashtra, India
Pfizer Investigational Site
Parel, Mumbai, India
Pfizer Investigational Site
Jaipur, Rajasthan, India
Pfizer Investigational Site
New Delhi, India
Pfizer Investigational Site
Dublin 24, Ireland
Pfizer Investigational Site
Dublin, Ireland
Pfizer Investigational Site
Jerusalem, Israel
Pfizer Investigational Site
Tel Hashomer, Israel
Pfizer Investigational Site
Bergamo, Italy
Pfizer Investigational Site
Brescia, Italy
Pfizer Investigational Site
Cattolica (RN), Italy
Pfizer Investigational Site
Cuneo, Italy
Pfizer Investigational Site
Legnago, VR, Italy
Pfizer Investigational Site
Modena, Italy
Pfizer Investigational Site
Napoli, Italy
Pfizer Investigational Site
Padova, Italy
Pfizer Investigational Site
Parma, Italy
Pfizer Investigational Site
Pavia, Italy
Pfizer Investigational Site
Perugia, Italy
Pfizer Investigational Site
Pordenone, Italy
Pfizer Investigational Site
Rimini, Italy
Pfizer Investigational Site
Roma, Italy
Pfizer Investigational Site
Roma, Italy
Pfizer Investigational Site
Roma, Italy
Pfizer Investigational Site
Torino, Italy
Pfizer Investigational Site
Seoul, Korea, Republic of
Pfizer Investigational Site
Seoul, Korea, Republic of
Pfizer Investigational Site
Beirut, Lebanon
Pfizer Investigational Site
Petaling Jaya, Selangor, Malaysia
Pfizer Investigational Site
Kuala Lumpur, Malaysia
Pfizer Investigational Site
Mexico, DF, Mexico
Pfizer Investigational Site
Mexico, DF, Mexico
Pfizer Investigational Site
Toluca, Estado de Mexico, Mexico
Pfizer Investigational Site
Guadalajara, Jalisco, Mexico
Pfizer Investigational Site
Merida, Yucatan, Mexico
Pfizer Investigational Site
Chihuahua, Mexico
Pfizer Investigational Site
Puebla, Mexico
Pfizer Investigational Site
Groningen, GR, Netherlands
Pfizer Investigational Site
Amsterdam, NH, Netherlands
Pfizer Investigational Site
Amsterdam, Netherlands
Pfizer Investigational Site
Rotterdam, Netherlands
Pfizer Investigational Site
Oslo, Norway
Pfizer Investigational Site
Ciudad de Panama, Panama
Pfizer Investigational Site
Panama, Panama
Pfizer Investigational Site
Lima, Peru
Pfizer Investigational Site
Lima, Peru
Pfizer Investigational Site
Quezon City, Philippines
Pfizer Investigational Site
Quezon City, Philippines
Pfizer Investigational Site
Gdansk, Poland
Pfizer Investigational Site
Lodz, Poland
Pfizer Investigational Site
Poznan, Poland
Pfizer Investigational Site
Warszawa, Poland
Pfizer Investigational Site
Wroclaw, Poland
Pfizer Investigational Site
Lisboa, Portugal
Pfizer Investigational Site
Porto, Portugal
Pfizer Investigational Site
Bucuresti, Romania
Pfizer Investigational Site
Cluj-Napoca, Romania
Pfizer Investigational Site
Obninsk, Kaluga region, Russian Federation
Pfizer Investigational Site
Chelyabinsk, Russian Federation
Pfizer Investigational Site
Moscow, Russian Federation
Pfizer Investigational Site
Belgrade, Serbia
Pfizer Investigational Site
Singapore, Singapore
Pfizer Investigational Site
Bratislava, Slovakia
Pfizer Investigational Site
Zilina, Slovakia
Pfizer Investigational Site
Ljubljana, Slovenia
Pfizer Investigational Site
Oviedo, Asturias, Spain
Pfizer Investigational Site
L'hospitalet Del Llobregat, Barcelona, Spain
Pfizer Investigational Site
Pamplona, Navarra, Spain
Pfizer Investigational Site
Baracaldo, Vizcaya, Spain
Pfizer Investigational Site
Barcelona, Spain
Pfizer Investigational Site
Barcelona, Spain
Pfizer Investigational Site
La Coruña, Spain
Pfizer Investigational Site
Madrid, Spain
Pfizer Investigational Site
Madrid, Spain
Pfizer Investigational Site
Madrid, Spain
Pfizer Investigational Site
Salamanca, Spain
Pfizer Investigational Site
Sevilla, Spain
Pfizer Investigational Site
Valencia, Spain
Pfizer Investigational Site
Göteborg, Sweden
Pfizer Investigational Site
Lund, Sweden
Pfizer Investigational Site
Stockholm, Sweden
Pfizer Investigational Site
Umeå, Sweden
Pfizer Investigational Site
Basel, Switzerland
Pfizer Investigational Site
Bellinzona, Switzerland
Pfizer Investigational Site
Bern, Switzerland
Pfizer Investigational Site
Biel, Switzerland
Pfizer Investigational Site
CH-4058 Basel, Switzerland
Pfizer Investigational Site
CH-4101 Bruderholz, Switzerland
Pfizer Investigational Site
CH-4410 Liesthal, Switzerland
Pfizer Investigational Site
Chur, Switzerland
Pfizer Investigational Site
Genève 14, Switzerland
Pfizer Investigational Site
Taipei, Taiwan
Pfizer Investigational Site
Taipei, Taiwan
Pfizer Investigational Site
Taoyun, Taiwan
Pfizer Investigational Site
Bangkok, Thailand
Pfizer Investigational Site
Bangkok, Thailand
Pfizer Investigational Site
Istanbul, Capa, Turkey
Pfizer Investigational Site
Istanbul, Cerrahpasa, Turkey
Pfizer Investigational Site
Whitchurch, Cardiff, United Kingdom
Pfizer Investigational Site
London, Se1 9rt, United Kingdom
Pfizer Investigational Site
Sutton, Surrey, United Kingdom
Pfizer Investigational Site
Leeds, West Yorkshire, United Kingdom
Pfizer Investigational Site
Belfast, United Kingdom
Pfizer Investigational Site
Birmingham, United Kingdom
Pfizer Investigational Site
Birmingham, United Kingdom
Pfizer Investigational Site
Bristol, United Kingdom
Pfizer Investigational Site
Cottingham, United Kingdom
Pfizer Investigational Site
Edinburgh, United Kingdom
Pfizer Investigational Site
Guildford, United Kingdom
Pfizer Investigational Site
London, United Kingdom
Pfizer Investigational Site
London, United Kingdom
Pfizer Investigational Site
London, United Kingdom
Pfizer Investigational Site
Manchester, United Kingdom
Pfizer Investigational Site
Northwood, United Kingdom
Pfizer Investigational Site
Nottingham, United Kingdom
Pfizer Investigational Site
Sheffield, United Kingdom
Pfizer Investigational Site
Southampton, United Kingdom
Pfizer Investigational Site
Swansea, United Kingdom
Pfizer Investigational Site
Caracas, Distrito Capital, Venezuela
Pfizer Investigational Site
Caracas, Estado Miranda, Venezuela
Pfizer CT.gov Call Center, Study Director
Pfizer